Previous Article | Next Article ![]()
Infection and Immunity, September 1999, p. 4443-4455, Vol. 67, No. 9
Department of Microbiology and Infectious
Diseases, University of Calgary Health Sciences Center, Calgary,
Alberta T2N 4N1,1 and Department of
Pediatrics, University of British Columbia, Vancouver, British
Columbia V5Z 4H4,2 Canada
Received 26 March 1999/Returned for modification 9 June
1999/Accepted 15 June 1999
Burkholderia cepacia is a frequent cause of respiratory
infections in cystic fibrosis patients. B. cepacia has been
shown to produce at least four siderophores which may play a role in the virulence of this organism. To characterize genes involved in the
synthesis of siderophores, Tn5-OT182 mutants were isolated in strain K56-2, which produces two siderophores, salicylic acid (SA)
and ornibactins. Two mutants were characterized that did not produce
zones on Chrome Azurol S agar in a commonly used assay to detect
siderophore activity. These mutants were determined to produce
sevenfold more SA than K56-2 yet did not produce detectable amounts of
ornibactins. These mutants, designated I117 and T10, had a transposon
insertion in genes with significant homology to pyoverdine biosynthesis
genes of Pseudomonas aeruginosa. I117 contained an
insertion in a pvdA homolog, the gene for the enzyme L-ornithine N5-oxygenase, which
catalyzes the hydroxylation of L-ornithine. Ornibactin
synthesis in this mutant was partially restored when the precursor
L-N5-OH-Orn was added to the
culture medium. T10 contained an insertion in a pvdD
homolog, which is a peptide synthetase involved in pyoverdine synthesis. Burkholderia cepacia is
an opportunistic pathogen that can cause severe respiratory infections
in patients with cystic fibrosis or chronic granulomatous disease
(21). Approximately 20% of cystic fibrosis patients
colonized with B. cepacia experience a rapid and often fatal
pulmonary decline (21). Potential virulence factors that may
contribute to the severity of B. cepacia infections include
siderophores. Iron is essential for microbial growth, but its
availability is very limited in mammalian hosts due to the presence of
iron-binding proteins such as transferrin and lactoferrin. To acquire
iron from the environment and to compete with transferrin or
lactoferrin for mammalian iron, many bacteria have evolved
high-affinity iron uptake systems, consisting of low-molecular-weight
iron chelators, called siderophores, and specific receptor-mediated
membrane-associated uptake mechanism (reviewed in references
8 and 37). B. cepacia
has been reported to produce four different siderophores, salicylic
acid (SA; formerly azurechelin), ornibactins, pyochelin, and cepabactin
(35, 36, 53, 54, 57, 65).
We have recently determined that SA and ornibactins are the predominant
siderophores produced by clinical isolates of B. cepacia (11). SA is produced by 92% of B. cepacia RAPD
(randomly amplified polymorphic DNA) types from cystic fibrosis
patients (11). SA, which is similar in structure to
pyochelin, has also been shown to function as a siderophore in
Pseudomonas aeruginosa and Pseudomonas fluorescens (65). Ornibactins are linear
hydroxamate-hydroxycarboxylate siderophores that are related in their
peptide structure to the pyoverdines produced by the fluorescent
pseudomonads P. aeruginosa and P. fluorescens
(36, 57). Ornibactins are composed of the conserved
tetrapeptide
L-Orn1(N Although the structure of ornibactins has been well defined, genes
involved in their biosynthesis and transport have not yet been
characterized. Because of their similarity to pyoverdines, it may be
hypothesized that biosynthetic enzymes for these siderophores are
conserved. Several genes have been identified which are required for
the synthesis of pyoverdines. The genetic loci involved in pyoverdine
biosynthesis have been mapped in P. aeruginosa to a 103-kb
region located at approximately 47 min of the PAO1 chromosome (1,
62, 68). pvdA encodes the enzyme
L-ornithine N5-oxygenase responsible
for catalyzing the hydroxylation of L-ornithine, thus
forming the hydroxamate ligands of pyoverdine (64).
pvdD encodes an enzyme similar to peptide synthetases from a
range of bacterial and fungal species that function in nonribosomal peptide synthesis (34). The recently characterized
pvdE gene has been shown to code for an ATP-binding cassette
membrane transporter protein involved in pyoverdine synthesis
(31). The cytA gene has also recently been shown
to be required for normal levels of pyoverdine production in P. fluorescens, in addition to being essential for cytochrome
c production (17). PvdS, a novel transcriptional factor belonging to the The objectives of the present study were to isolate B. cepacia mutants altered in the biosynthesis of ornibactins.
Transposon mutagenesis with Tn5-OT182 was used to generate a
series of mutants deficient in siderophore synthesis. Two genes were
identified as directly implicated in ornibactin synthesis. The
importance of ornibactin biosynthesis in the virulence of B. cepacia was also investigated.
Strains, plasmids, and growth conditions.
The bacterial
strains and plasmids used in this study are described in Table
1. B. cepacia K56-2 was
originally isolated from the sputum of a cystic fibrosis patient. This
strain produces salicylic acid and ornibactins, negligible amounts of
pyochelin, and no cepabactin (11, 27). For genetic
manipulations, cultures were routinely grown at 37°C in Luria-Bertani
(LB) broth (Life Technologies, Burlington, Ontario, Canada) or
Bacto-Terrific broth (Difco, Detroit, Mich.). Pseudomonas Isolation
Agar (Difco) was used to recover B. cepacia transformants
after electroporation with plasmids. Trypticase soy agar was used to
quantitate bacteria in lung homogenates. When appropriate, antibiotics
were added at the following concentrations: 100 µg of ampicillin, 15 µg of tetracycline, and 1.5 mg of trimethoprim per ml for
Escherichia coli and 300 µg of tetracycline, 100 µg of
streptomycin, and 100 µg of trimethoprim per ml for B. cepacia. A 100-mg/ml stock solution of trimethoprim was prepared
in N,N-dimethyl-acetimide.
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Role of Ornibactin Biosynthesis in the Virulence of
Burkholderia cepacia: Characterization of pvdA,
the Gene Encoding L-Ornithine
N5-Oxygenase
and
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
-Galactosidase activity was iron regulated in both I117
and T10, suggesting that the transposon was inserted downstream of an
iron-regulated promoter. Tn5-OT182 contains a
lacZ gene that is expressed when inserted downstream of an
active promoter. Both I117 and T10 were deficient in uptake of iron
complexed to either ornibactins or SA, suggesting that transposon
insertions in ornibactin biosynthesis genes also affected other
components of the iron transport mechanism. The B. cepacia
pvdA homolog was approximately 47% identical and 59% similar to
L-ornithine N5-oxygenase from
P. aeruginosa. Three clones were identified from a K56-2
cosmid library that partially restored ornibactin production, SA
production, and SA uptake to parental levels but did not affect the
rate of 59Fe-ornibactin uptake in I117. A chromosomal
pvdA deletion mutant was constructed that had a phenotype
similar to that of I117 except that it did not hyperproduce SA. The
pvdA mutants were less virulent than the parent strain in
chronic and acute models of respiratory infection. A functional
pvdA gene appears to be required for effective colonization
and persistence in B. cepacia lung infections.
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
-OH,
N
-acyl)-D-threo-Asp(
-OH)-L-Ser-L-Orn4(N
-OH,N
-formyl)-1,4-diaminobutane.
The acyl groups of Orn1 vary in length and include
3-hydroxybutanoic acid, 3-hydroxyhexanoic acid, and 3-hydroxyoctanoic
acid, forming the three different ornibactins, which are designated
ornibactin-C4, ornibactin-C6, and
ornibactin-C8 according to their acyl chain length
(57, 58). Ornibactins are produced by 87% of B. cepacia RAPD types from cystic fibrosis patients (11).
E family of RNA polymerase sigma
factors, is required for the transcription of pyoverdine biosynthetic
genes (10, 39).
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
TABLE 1.
Bacterial strains and plasmids used in this study
Tn5-OT182 mutagenesis. Tn5-OT182 (33) was introduced into K56-2 by conjugation with SM10(pOT182) as previously described (27). Transconjugants were selected on LB agar containing 300 µg of tetracycline and 100 µg of streptomycin per ml and 100 µM FeCl3 to select against wild-type B. cepacia and the E. coli donor strain. Tn5-OT182 insertion mutants were screened for mutations in genes involved in siderophore biosynthesis on Chrome Azurol S (CAS) plates (51). Mutants that did not produce detectable zones after 2 to 3 days of incubation at 32°C were selected for further characterization.
DNA manipulations.
Molecular biology techniques were
performed as generally described by Sambrook et al. (44).
Genomic DNA was isolated from K56-2 as described by Ausubel et al.
(3). Colony hybridizations were performed as previously
described (68). Recombinant plasmids were electroporated
into E. coli by using a Gene Pulser (Bio-Rad, Richmond,
Calif.) according to the manufacturer's recommendations or into
B. cepacia I117 as previously described (12). For
the self-cloning of B. cepacia DNA from Tn5-OT182
mutants, approximately 5 µg of genomic DNA was digested with an
appropriate restriction enzyme, ligated, and transformed into E. coli DH5
cells made competent by treatment with
CaCl2 (28). For cloning of the parental pvdA gene, appropriate size restriction fragments were
isolated by sucrose density gradient centrifugation of restriction
endonuclease digested genomic DNA (20) and ligated into
pNOT19 (47).
Construction of a cosmid library. A novel broad-host-range cosmid vector, pScosBC1, derived from the ColE1-based cloning vector pSuperCos1 (67) (Stratagene, La Jolla, Calif.), was used to construct a cosmid library of B. cepacia K56-2. Cosmid pScosBC1 was constructed as follows. A 1.97-kb fragment encoding the kanamycin resistance gene and simian virus 40 origin of pSuperCos1 was removed from this vector by digestion with the endonucleases HpaI and PvuII, creating plasmid pScosDHP1. The 1.8-kb PstI-generated replication stabilizing fragment from pRO1614, which facilitates the stable maintenance of ColE1-based replicons in a wide range of gram-negative bacteria (46), was inserted into NsiI of pScosDHP1, creating plasmid pScosRSF.2. To enable selection of this vector in B. cepacia, a 1-kb Tpr gene cassette was added to pScosRSF.2. The cassette was derived as follows. Plasmid pCHR61 encoding the Tpr resistance gene from plasmid R388 (45) was partially digested with Sau3A1, and fragments of approximately 1 kb were ligated into the vector backbone of plasmid pUC-GM (49) isolated by restriction with BamHI. Several Tpr clones resulting from this ligation were screened, and one clone (which liberated a 1-kb Tpr gene cassette after digestion with either HindIII, PstI, SalI, SphI, or XbaI) was designated plasmid pUC-TP. A 1-kb SalI Tpr cassette isolated from pUC-TP was ligated into a single AvaI site within pSCOSRSF.2 to create the final broad-host-range cosmid vector pScosBC1.
A cosmid library of B. cepacia K56-2 was constructed in pScosBC1 as follows. Genomic DNA was extracted from strain K56-2 as previously described (30). Approximately 2 µg of K56-2 DNA partially digested with Sau3A1 (ranging from 20 to 35 kb) was combined with 2 µg of pScosBC1 linearized with BamHI, and the mixture was ligated in a 20-µl reaction mixture for 4 h at 16°C. After ligation, 4 µl of the reaction mixture was packaged into the bacteriophage lambda by using a commercial kit which selectively packages large recombinant cosmids (Gigapack III XL; Stratagene). The resulting phage extract was transfected into E. coli XL1-Blue MR. The average insert size of library clones was 33 kb, and less than 3% of the clones were nonrecombinant. A total of 1,596 cosmids (sufficient to cover the 8-Mb B. cepacia genome [7, 43] approximately six times) were picked into 96-well plates. After overnight growth, each 96-well grid was replica plated onto positively charged nylon membranes (Boehringer Mannheim, Laval, Quebec, Canada) which had been placed onto selective agar. Dimethyl sulfoxide was then added to a final concentration of 8% to each well, and the cosmid library was frozen at
70°C. After
further overnight growth, DNA from each gridded clone was immobilized
onto the nylon membranes as described by the manufacturer's guidelines
(Boehringer Mannheim).
Nucleotide sequencing. Nucleotide sequencing was performed by using the ABI PRISM DyeDeoxy Termination Cycle Sequencing System with AmpliTaq DNA polymerase (Perkin-Elmer Corp.). DNA sequencing reactions were analyzed with an ABI 1373A DNA Sequencer by the University Core DNA Services (University of Calgary). The oligodeoxynucleotide OT182-LT (5'-GATCCTGGAAAACGGGAAAG-3') was used to initiate DNA sequence reactions with plasmids obtained from Tn5-OT182 mutants by self-cloning. Custom oligonucleotides were synthesized by the University Core DNA Services or Life Technologies. Analysis of the sequence was performed with PC/Gene software (Intelligenetics, Mountain View, Calif.). The BLASTX and BLASTN programs were used to search the nonredundant sequence database for homologous sequences (29).
PFGE of genomic DNA. Separation of intact chromosomes was carried out by pulsed-field gel electrophoresis (PFGE) by using a protocol adapted from previous methods (7, 43). Bacterial growth from 5 ml of LB overnight culture was harvested by centrifugation and resuspended to an A620 of 0.8 to 0.9 in SE buffer (75 mM NaCl, 25 mM EDTA, pH 7.4). This suspension was then concentrated eightfold by centrifugal harvesting of bacteria, followed by suspension of the pellet in one-eighth of the original volume of SE buffer. The concentrated bacterial suspension was briefly warmed to 45°C, mixed gently with an equal volume of molten 2% low-melting-point agarose (Type 7; Sigma-Aldrich Canada, Oakville, Ontario, Canada) kept at the same temperature, and poured into 70-µl disposable plug molds (Bio-Rad, Mississauga, Ontario, Canada). After cooling to 4°C for 15 min the solidified plugs (three to five per tube) were placed in 10 ml of PEN buffer (0.5 M EDTA [pH 9.6] plus 1% N-lauroyl sarcosine containing 1 mg of pronase [Boehringer Mannheim] per ml) in a 15-ml sterile tube. Plugs were incubated with gentle rocking for 48 h at 37°C and then washed thoroughly with several volume changes of TE buffer (44). Slices were then cut from plugs and loaded on a 0.8% agarose gel (14 by 13 cm) made with TAE electrophoresis buffer (44). Intact chromosomal DNA was separated by PFGE (Bio-Rad CHEF DR-II apparatus) at 3 V/cm for 64 h, with the pulse switch time ramped from 250 to 900 s.
Siderophore production assays. Siderophore activity was measured by CAS assays (51). SA was isolated and quantitated by thin-layer chromatography of ethyl acetate-extracted culture supernatants as previously described (54). Ornibactin production was assayed as previously described (11, 27). Briefly, supernatants were lyophilized and extracted with methanol, and ornibactins were separated by Sephadex LH-20 (Pharmacia) column chromatography. Fractions containing CAS activity were pooled, and the total ornibactin concentration was estimated by using the CAS assay.
Iron uptake assays. For iron uptake assays, cultures were grown to an A600 of 0.3, washed once, and resuspended to a final A600 of 0.3 in nitrogen-free succinate medium (36), or cultures were grown to late log phase (A600 of 1.0 to 1.4), and the cells were then washed and resuspended to a final A600 of 0.3. Similar rates of uptake were observed by using either procedure (data not shown). Ornibactins (3.6 nmol) were mixed with an equal amount of 59FeCl3 in a total volume of 100 µl and equilibrated for 10 to 30 min prior to the assay. Uptake reactions were initiated by the addition of 100 µl of the 59Fe-ornibactin mixture to a 10-ml cell suspension. Then, 1-ml samples of these reaction mixtures were removed at selected intervals, filtered through cellulose acetate 0.45-µm-pore-size filters (Sartorius, GmbH), and washed with 3 ml of 10 mM Tris (pH 7.5)-0.9% NaCl. The amount of 59Fe accumulated on the filters was measured in an LKB Compugamma counter. SA uptake assays were performed as described above except that 7.2 nmol of SA was equilibrated with 3.6 nmol of 59FeCl3 and 100 µl of 59Fe-SA was used to initiate the uptake reactions (54).
-Galactosidase assays.
Cultures were grown to an
A600 of 0.5 in TSBD-C medium (42) in
the presence or absence of 50 µM FeCl3, and
-galactosidase assays were performed as previously described by
Miller (38).
Effect of L-N5-hydroxyornithine on ornibactin production. L-N5-Hydroxyornithine (L-N5-OH-Orn) was prepared by the acid hydrolysis of rhodoturulic acid as previously described (2). K56-2 and I117 were grown in succinate medium, 0.5% glucose, and 400 µM L-N5-OH-Orn (pH 7.0) for 40 h at 32°C. Ornibactin production was determined by measuring the CAS activity of culture supernatants.
Animal studies. Chronic infection experiments were performed in the respiratory infection model in rats as described by Cash et al. (6). Groups of 16 male Sprague-Dawley rats weighing 150 to 170 g (Charles River Canada, Inc.) were tracheostomized under anesthesia and inoculated with the appropriate strain embedded in agar beads as previously described (6). On days 7 and 28 postinfection, the lungs from four animals in each group were removed aseptically and homogenized (Polytron Homogenizer; Brinkman Instruments, Westbury, N.Y.) in 3 ml of phosphate-buffered saline (0.05 M [pH 7.2] containing 0.9% saline) (PBS). Serial dilutions were plated on Trypticase soy agar or Trypticase soy agar plus the appropriate antibiotic. The lungs of four additional animals in each group were removed en bloc, fixed in 10% formalin, and examined for qualitative and quantitative pathological changes as previously described (15, 55). Infiltration of the lung with inflammatory cells and exudate was measured by the point counting method (15, 55). Briefly, with a Zeiss integrating eyepiece (Zeiss, Oberkochen, Germany), the number of points overlying the surface area of the infiltrate was divided by the total number of points counted over the entire surface area of the section of the left lobe to measure the percentage of infiltration.
Acute infections were performed in neutropenic mice infected by aerosol inoculation. Swiss Webster male mice (18 to 20 g), five per group, were made neutropenic by intraperitoneal injection of cyclophosphamide (150 mg/kg) on days 4, 2, and 0 prior to infection (9). For initiation of bacterial infections by an aerosol route, PBS dilutions of a 10-ml overnight culture were washed once in PBS and resuspended in 10 ml of PBS. Bacteria (ca. 6 × 108 CFU/ml) were aerosolized into animals by using an aerosol chamber designed for small-animal use (5). The aerosol chamber was housed in a Biosafety Cabinet in a level 2 containment facility with the airflow isolated for additional safety. The chamber is designed to accept animals ranging in size from 20 to 250 g, and it is equipped with sampling ports for an Anderson Air Sampler to allow the monitoring of the size of the particles. The aerosol is removed through HEPA-filtered adjustable vacuum flow which allows the control of flow rates. The aerosol flow rates are calibrated by using fluorescent microspheres obtained from Duke Scientific Corporation, and this was done prior to each aerosol treatment. On days 0 (ca. 2 h), 3, and 7 after bacterial inoculation by the aerosol route, animals were sacrificed, and their lungs were removed and examined for bacterial counts.Nucleotide sequence accession number. The nucleotide sequence for the pvdA gene has been deposited in GenBank and assigned accession no. AF013993. The nucleotide sequence of vectors pScosBC1 and pUC-TP was assembled from the published sequences of their components held within GenBank; each complete sequence has been assigned accession no. AF136442 and AF136443, respectively.
| |
RESULTS |
|---|
|
|
|---|
Isolation and characterization of B. cepacia siderophore mutants. The objectives of this study were to isolate mutants altered in the synthesis of ornibactins. The transposon Tn5-OT182, which contains a tetracycline resistance determinant and a pBR325 origin of replication to allow the cloning of DNA adjacent to the transposon without the construction of genomic libraries, was used to generate mutants (33). This transposon also contains a promoterless lacZ reporter gene, allowing the formation of lacZ transcriptional fusions when inserted downstream from a functional promoter (33).
Approximately 5,300 Tcr Smr transconjugants from four independent mutagenesis experiments were screened for mutations in genes involved in siderophore synthesis on CAS agar (51). Colonies that produce siderophores on this medium remove iron from the blue CAS dye, and orange zones are formed around the colonies. Strains lacking siderophores produce no zones or very small zones compared to the parent strain. Nine mutants lacking zones on CAS agar were identified that contained Tn5-OT182 in a unique location, as determined by Southern hybridization (data not shown). The region of the chromosome flanking Tn5-OT182 in each mutant was mapped by using Southern hybridization analysis of DNA digested with EcoRI, NotI, BamHI, XhoI, SalI, ClaI, HindIII, SstI, and SmaI, and a probe internal to Tn5-OT182. An appropriate restriction enzyme which would yield a fragment containing the origin of replication, the Tcr determinant, and approximately 0.5 to 5.0 kb of DNA outside the transposon was then selected for cloning the flanking region (33). Chromosomal DNA was digested with this enzyme, ligated, and transformed into E. coli DH5
. For
some mutants, DNA from both the right and left sides of the transposon
was cloned (Table 1). A primer specific to the end of
Tn5-OT182 was used to perform a cycle sequencing reaction on
the plasmids isolated by self-cloning (13). Generally, about
300 to 400 bp of sequence was obtained and used to search the
nonredundant protein sequence database by using the local alignment
search tool BLASTX (29) through the National Center for
Biotechnology Information at the National Institutes of Health. Two of
the mutants had Tn5-OT182 insertions in genes with homology to siderophore biosynthetic genes, and these mutants were selected for
further characterization.
Mutants I117 and T10 contained insertions in genes homologous to
P. aeruginosa genes involved in pyoverdine synthesis. The gene inactivated in I117 had homology to the pvdA gene,
which is the structural gene for the enzyme L-ornithine
N5-oxygenase, which catalyzes the hydroxylation
of L-ornithine, an early step in the biosynthesis of the
peptide moiety of pyoverdine (64). Mutants lacking this
enzyme require L-N5-OH-Orn for
pyoverdine synthesis (66). In the mutant T10, the transposon
was inserted into a gene with homology to a peptide synthetase gene,
pvdD, which has homology to peptide synthetase genes
involved in nonribosomal peptide synthesis (34). P. aeruginosa pvdD encodes a 2,448-amino-acid residue protein with a
predicted molecular mass of 273,061 Da. It contains two highly similar
domains of ca. 1,000 amino acids each. Each domain is likely involved in the recognition, activation, and incorporation of a specific amino
acid into the peptide moiety of pyoverdine (34). The
insertion in T10 is located in one of the two similar domains, since
the portion sequenced has homology to both domains.
Characterization of mutants I117 and T10.
Since mutants I117
and T10 were determined to have transposon insertions in genes
homologous to pyoverdine biosynthetic genes which are likely similar to
genes directly involved in ornibactin synthesis, these mutants were
selected for further characterization. These mutants were grown in CAA
medium for 24 h to stationary phase, and culture supernatants were
assayed for CAS activity (Table 2). I117
and T10 had no detectable CAS activity. These mutants were also unable
to grow in the presence of the iron chelator ethylenediamine-di(o-hydroxy-phenylacetic acid (EDDHA; data
not shown). Ornibactins were quantitated by measuring CAS activity in
methanol extracts from supernatants of cultures grown in succinate medium and chromatographed on Sephadex LH-20. I117 and T10 produced no
detectable ornibactins (Table 2).
|
-galactosidase produced
corresponds to the activity of the fused promoter upstream from the
inserted lacZ gene. Since siderophore production is
regulated by the amount of iron in the culture medium, the amount of
-galactosidase produced was determined in cultures grown to the same
stage of growth at an A600 of 0.5 in TSBD-C and
in TSBD-C plus 50 µM FeCl3. B. cepacia K56-2
produces barely detectable levels of
-galactosidase (Table 3). Mutants I117 and T10 produced
-galactosidase when grown in low-iron medium but only produced
background levels of
-galactosidase in medium with 50 µM
FeCl3, which was not significantly different than K56-2.
There was at least a 90% decrease in
-galactosidase production in
medium with iron added. This indicates that Tn5-OT182 is
inserted downstream of an active iron-regulated promoter in both I117
and T10. Sequence analysis with the primer OT182-L confirmed the
orientation of the pvdA and pvdD genes with
respect to the lacZ gene.
|
|
Characterization of the B. cepacia pvdA gene.
L-Ornithine N5-oxygenase is a key
step in the biosynthesis of pyoverdine type siderophores since it is
essential for the generation of the hydroxamate residues of these
molecules (64). Therefore, the pvdA gene from
B. cepacia was isolated to further characterize this
essential step in the biosynthesis of ornibactins. By using a 1.2-kb
SalI-BamHI fragment from pPDI117-2 as a probe in
Southern hybridization, a 6.1-kb SphI fragment from K56-2
was identified which contained the entire pvdA gene. This
fragment was cloned into pNOT19 (pPD519) and was used to determine the
nucleotide sequence of the pvdA gene. An open reading frame
of 1,332 bp was identified which began with an ATG at position 232 of
the deposited sequence (Fig. 2, residue
no. 1) and ended with a TGA stop codon at position 1564. There was a
putative ribosome binding site, AGGGA, 9 bp upstream of the start codon
(data not shown). The protein encoded by pvdA is predicted
to be a 444-amino-acid peptide with a molecular mass of 50 kDa. The
estimated isoelectric point (pI) is 9.1. A partial open reading frame
was detected with a stop codon ending just 6 bp upstream of
pvdA. This open reading frame did not have any homologous
sequences in the database. No evident
35 and
10 consensus promoter
sequences were identified within the 231 bp sequenced upstream of
pvdA. There were no sequences with significant homology to
the
10 region upstream of the T1 promoter of P. aeruginosa
pvdA or to the proposed
35 consensus sequence of
E-dependent promoters. There were no apparent consensus
sequences in this upstream region which might be predicted to bind PvdS or Fur homologs (26, 41).
|
|
|
-galactosidase activity, indicating that the pvdA gene
was not expressed from this construct and therefore was not able to
complement I117.
In order to isolate a larger fragment with the potential to complement
I117, a cosmid library of K56-2 was constructed in the vector pScosBC1
and screened for clones containing pvdA by colony
hybridization. Six positive clones were identified, and three were
electroporated into I117 and analyzed for complementation. I117
containing either of these clones (pSBC-4, pSBC-8, and pSBC-13) produced zones on CAS agar. The CAS activity in culture supernatants of
these strains is shown in Fig. 4B. These cosmids were able to partially
restore CAS activity in I117 but not to parental levels. pSBC-4 and
pSBC-8 restored CAS activity to slightly higher levels than pSBC-13.
The ability of these cosmids to complement the defects in siderophore
uptake by I117 was examined, and none of the cosmids had an effect on
59Fe-ornibactin uptake (Fig.
5A). However, all three of the cosmids partially restored the ability of I117 to accumulate
59Fe-SA (Fig. 5B). These cosmids also partially restored
the level of SA produced by I117 to levels between that of the K56-2
and I117 containing the vector control (data not shown). The three cosmids contained overlapping inserts ranging in size from 35 to 40 kb.
|
|
|
Role of the pvdA gene in virulence.
B.
cepacia causes chronic respiratory infections, and the agar bead
model of Cash et al. (6) has previously been used to assess
the virulence of this organism in chronic lung infections (56,
59). Therefore, this model was selected to determine the
importance of ornibactin biosynthesis in the pathogenesis of B. cepacia infections. In one experiment, rats were infected with
K56-2 and I117. Quantitative bacteriology and quantitative pathology
analysis were performed on days 7 and 28 postinfection (p.i.). Rats
were infected with approximately 104 CFU of bacteria. On
day 7 p.i., the numbers of K56-2 in the lungs had increased to
4.3 × 106 CFU/ml or 1.3 × 107
CFU/lung, whereas the numbers of I117 had decreased to 3.1 × 102 CFU/ml (Table 4). On day
28 p.i., K56-2 continued to colonize the lungs at a concentration
of 3.3 × 105 CFU/ml. I117, however, was recovered
from the lungs at a concentration 4 logs lower than K56-2 on both days
7 and 28 p.i. In a second experiment, K56-2 was compared to
K56pvdA::tp by using the same protocol. On day
7 p.i. the number of K56-2 recovered from the lung was more than 2 logs higher than the mutant, and on day 28 p.i.
K56pvdA::tp was no longer recovered from the
lungs, indicating that the infection had cleared (Table 4).
|
|
| |
DISCUSSION |
|---|
|
|
|---|
B. cepacia ornibactin-deficient mutants identified by transposon insertion mutagenesis had insertions in genes homologous to genes involved in pyoverdine production in P. aeruginosa. Due to the degree of sequence homology and similar function, these genes were given the same designation as their P. aeruginosa homologs, pvdA and pvdD, respectively. K56-2, the parent strain, produces three ornibactins, designated ornibactin-C4, ornibactin-C6, and ornibactin-C8, which vary in the length of the acyl group. I117 and T10 did not produce any of the three ornibactin molecules.
The pvdA gene was cloned and sequenced from B. cepacia K56-2, and its product was determined to have significant
homology with other
-amino acid oxygenases. Therefore, enzymes
involved in the hydroxylation of an
-amino acid and its acylation
are conserved steps in the synthesis of hydroxamate-like siderophores. These enzymes characterize a unique reaction that is only found in
bacterial and fungal species (64) and, therefore, may
represent a potential therapeutic target for the development of
antimicrobial compounds.
Previously, Visca et al. (64), using a DNA probe containing the P. aeruginosa pvdA gene, demonstrated that B. cepacia and P. fluorescens DNA fragments hybridized with the probe, suggesting that L-ornithine N5-oxygenases are conserved among Pseudomonas and Burkholderia species. Tabacchioni et al. (61), however, were not able to demonstrate hybridization of B. cepacia DNA with the same P. aeruginosa pvdA probe. These conflicting reports, which included the same strain, BC TVV75, suggest that even though the L-ornithine N5-oxygenases are very similar between these two species, hybridization results with the two pvdA genes are somewhat variable. Therefore, it may have been difficult to clone the B. cepacia pvdA gene by using a hybridization strategy with a P. aeruginosa pvdA probe.
Despite the extensive similarity between the PvdA proteins of B. cepacia and P. aeruginosa, some differences have also
been observed. Pyoverdine synthesis is restored to wild-type levels when a P. aeruginosa pvdA mutant is fed the precursor
L-N5-OH-Orn (46). In
B. cepacia, provision of the precursor
L-N5-OH-Orn only restored ornibactin
yields to approximately 30% of parental levels; however, there may be
differences between these two organisms in their abilities to take up
this compound. In P. aeruginosa, a 1.7-kb SphI
fragment containing the pvdA gene was sufficient to
complement a pvdA mutant and fully restore pyoverdine synthesis (64). In B. cepacia, attempts to
complement a pvdA mutant with a 6.1-kb SphI
fragment containing the pvdA gene were not successful in
restoring ornibactin biosynthesis. Construction of a
pvdA::lacZ fusion in this construct
confirmed that additional sequences not contained on the 6.1-kb
SphI fragment were required for pvdA expression.
The vector pScosBC1 containing 35- to 40-kb inserts that included
pvdA was able to restore ornibactin synthesis to
approximately 30% of parental levels. Although both B. cepacia pvdA and pvdD were found to be iron regulated, as shown
by the effect of iron on
-galactosidase activity in the
transposon-generated lacZ fusion, no promoter regions
similar to those described for P. aeruginosa pvdA
(26) were identified within the 231 bp sequenced upstream of
B. cepacia pvdA. These studies suggest that, although the
enzymes in the biosynthetic pathways of pyoverdine and ornibactins may
be highly conserved, there may be differences in the organization and
regulation of genes required for the biosynthesis and uptake of these siderophores.
A probe constructed from the pvdD sequences flanking the transposon insertion did not hybridize to pPD519, indicating that pvdD is not adjacent to pvdA. This probe did hybridize to the cosmid clones, indicating that at least a portion of the pvdD gene is contained within these 35- to 40-kb fragments (data not shown).
The B. cepacia pvdA and pvdD mutants were determined to be defective in the uptake of ornibactins even when exogenous ornibactins were added to the culture medium to induce the expression of the ornibactin transport mechanism. In P. aeruginosa, the pvdD gene has been shown to be located just upstream of fpvA, the gene for the outer membrane receptor for pyoverdine (34). The two open reading frames are in the opposite orientation. Although the outer membrane receptor(s) for ferric ornibactins have not yet been described, we compared the outer membrane protein profiles of K56-2, I117, and T10 grown in low-iron and high-iron media for the absence of any iron-regulated proteins (data not shown). There were no dramatic differences observed in the outer membrane protein profiles between either of these mutants and the parent strain, suggesting that these mutants were not deficient in the expression of a specific ornibactin receptor. I117 and T10 were also deficient in the uptake of SA. These data suggest that the transposon insertions in these strains are also affecting a gene that is required for both siderophore-mediated iron transport systems. The transposon may be causing polar effects on a gene downstream of the insertion site. Mutations in tonB, exbB, or exbD homologs, for example, would likely have phenotypes similar to those of I117 and T10 in terms of their inability to accumulate iron complexed to various siderophores (4). It is also possible that there is a common enzyme required for the release of 59Fe from the siderophore that is affected by the transposon insertion. Insertion of Tn5-OT182 does not have nonspecific effects on siderophore-mediated iron uptake, as many other K56-2 isolates containing transposon insertions had normal iron uptake phenotypes (data not shown). An allelic exchange mutant created by insertion of a Tpr cassette in the pvdA gene was also deficient in uptake of either 59Fe-ornibactins or 59Fe-SA, suggesting that ornibactins are required for optimum expression of some components of siderophore-mediated iron uptake mechanisms. It is not clear why ornibactin biosynthesis would be required to induce the expression of genes involved in the SA uptake system unless these genes encoded proteins that were common to both systems.
I117 and T10 hyperproduced SA, which suggests that the genes involved in SA biosynthesis are upregulated when ornibactins are not produced. Strain K56-2 does not produce cepabactin and produces very low levels of pyochelin. No dramatic increase in the yields of pyochelin were observed in any of these mutants, and cepabactin production was not detected, suggesting that the upregulation of SA observed may be specific for this siderophore or that SA is the only siderophore that K56-2 is capable of synthesizing in greater amounts.
Previously, SA has been shown to bind iron, remove iron from transferrin in an equilibrium dialysis assay, promote growth in iron-restricted conditions, and promote iron uptake (54, 65). Purified SA has been shown to have weak activity in the CAS assay, but it requires the addition of 5-sulfosalicylic acid (54). The current study indicates that the levels of SA produced in the culture medium are not active in the CAS assay, even in the mutants that produce up to 10-fold-higher amounts of SA than the parent strain. The increased production of SA in ornibactin mutants may be a necessary response due to the apparent lower affinity for iron of SA compared to ornibactins and the reduced ability of these mutants to take up iron-SA complexes. K56pvdA::tp produced levels of SA only slightly greater than the parental levels of SA. The increase observed may be more due to the level of iron starvation of the cells than to a specific upregulation of SA biosynthesis due to this pvdA mutation. These data suggest that the increase in SA production observed in I117 and T10 may be due to polar effects of the transposon.
Since pPD519 containing approximately 1 kb of DNA upstream of the pvdA gene was not sufficient for complementation of ornibactin production in I117, a cosmid library of K56-2 was constructed. Three cosmid clones that contained pvdA complemented CAS activity in I117 and partially restored SA production and uptake to parental levels. The cosmids were not examined for their ability to complement K56pvdA::tp, since the resistance marker on both this mutant and the cosmid vector is trimethoprim. The cosmids were found to be somewhat unstable in I117 and were not well maintained in the absence of antibiotic selection. It was also observed that fragments of DNA were frequently lost from these vectors, a result possibly due to recombination. This may be the reason that siderophore production and uptake were not complemented to parental levels. The partial complementation may also be due to low levels of gene expression from these vectors in I117. It was surprising that these cosmids were able to partially restore SA-mediated iron uptake, but not Fe-ornibactin uptake. They may not be large enough to contain the appropriate genes, or the levels of ornibactin produced by I117 containing these clones may be too low to induce the required component(s) of the ornibactin uptake system.
The ability of B. cepacia to produce and take up ornibactin was demonstrated to be critical in the establishment of infections by using an acute lung model. I117 was only transiently able to colonize lungs of neutropenic mice and was almost cleared from the lungs by days 3 and 7 p.i. This suggests that iron may be required for some mechanisms involved in adherence or colonization. In the agar bead infection model, I117 and K56pvdA::tp were able to persist in the lung for at least 7 days p.i. but at a significantly lower level than was the parent strain. On day 28 p.i., most of these animals had also cleared the pvdA mutant strains from the lungs, whereas the parent strain maintained an infection level of approximately 105 CFU. The degree of pathology observed in animals infected with the pvdA mutants was only 40 to 50% of that observed in lungs of animals infected with K56-2 on day 7 p.i. and only 25 to 30% on day 28 compared to strain K56-2. These mutants were severely compromised in their ability to acquire iron since they were also at least partially deficient in their ability to take up iron complexed to SA. These strains also do not produce pyochelin, which previously has been shown to contribute to virulence of B. cepacia respiratory infections (52, 56). It would be interesting to examine the contribution of ornibactin synthesis and uptake to virulence in a strain that produces pyochelin and/or cepabactin.
It is of significant interest to note the differences in the histopathological picture associated with B. cepacia versus those observed in P. aeruginosa infections of murine lungs. The lungs of both mice and rats infected with B. cepacia presented a histopathological picture characterized by a mixed cellular infiltrate composed predominantly of mononuclear phagocytes and lymphocytes. This is contrasted with the histopathological changes associated with P. aeruginosa infections of murine lungs that are characterized by multiple microabscesses, mucus plugging, and alveolar destruction (6). The reasons for these very different histopathological pictures are not clear; however, the explanation for these differences is unlikely to be associated with iron uptake since there were no qualitative differences in the histopathology observed between B. cepacia K56-2 and the mutant strains I117 and K56pvdA::tp. Studies are ongoing to determine those B. cepacia factors that might play a role in the histopathological changes associated with lung infections due to these organisms.
| |
ACKNOWLEDGMENTS |
|---|
This study was supported by grants from the Canadian Cystic Fibrosis Foundation to P.A.S. and E.M. and from the Animal Studies Core of the Special Program in Applied Therapeutics (SPARX) from the CCFF to D.E.W.
We thank Francis Green for assistance with the interpretation of the pathology, Jocelyn Bischof for technical assistance with construction of the cosmid library, and Tod Strugnell for technical assistance with the animal experiments.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Microbiology and Infectious Diseases, University of Calgary Health Sciences Center, 3330 Hospital Dr. NW, Calgary, Alberta, Canada T2N 4N1. Phone: (403) 220-6037. Fax: (403) 270-2772. E-mail: psokol{at}ucalgary.ca.
Present address: Cardiff School of Biosciences, Cardiff University,
Cardiff, Wales CF1 3T2, United Kingdom.
Editor: E. I. Tuomanen
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Ankenbauer, R.,
L. Hanne, and C. D. Cox.
1986.
Mapping of mutations in Pseudomonas aeruginosa defective in pyoverdin production.
J. Bacteriol.
167:7-11 |
| 2. | Atkin, C. L., and J. B. Neilands. 1968. Rhodotorulic acid, a diketopiperazine dihydroxamic acid with growth-factor activity. I. Isolation and characterization. Biochemistry 7:3734-3739[Medline]. |
| 3. | Ausubel, F. M., R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl (ed.). 1989. Current protocols in molecular biology, vol. 1. John Wiley & Sons, Inc., New York, N.Y. |
| 4. | Braun, V., K. Gunter, and K. Hantke. 1991. Transport of iron across the outer membrane. Biol. Metals 4:14-22[Medline]. |
| 5. | Cantin, A. M., and D. E. Woods. Prolastin suppresses lung damage, inflammation and bacterial proliferation in a model of chronic Pseudomonas aeruginosa lung infection. Am. Rev. Res. Crit. Care Med., in press. |
| 6. | Cash, H. A., D. E. Woods, B. McCullough, W. G. Johanson, and J. A. Bass. 1979. A rat model of chronic respiratory infection with Pseudomonas aeruginosa Am. Rev. Respir. Dis. 119:453-459. |
| 7. |
Cheng, H.-P., and T. G. Lessie.
1994.
Multiple replicons constituting the genome of Pseudomonas cepacia 17616.
J. Bacteriol.
176:4034-4042 |
| 8. |
Crosa, J. H.
1989.
Genetics and molecular biology of siderophore-mediated iron transport in bacteria.
Microbiol. Rev.
53:517-530 |
| 9. |
Cryz, S. J., Jr.,
E. Furer, and E. Germanier.
1983.
Simple model for the study of Pseudomonas aeruginosa infections in leukopenic mice.
Infect. Immun.
39:1067-1071 |
| 10. |
Cunlliffe, H. E.,
T. R. Merriman, and I. A. Lamont.
1995.
Cloning and characterization of pvdS, a gene required for pyoverdine synthesis in Pseudomonas aeruginosa: PvdS is probably an alternative sigma factor.
J. Bacteriol.
177:2744-2750 |
| 11. |
Darling, P.,
M. Chan,
A. Cox, and P. A. Sokol.
1998.
Siderophore production by cystic fibrosis isolates of Burkholderia cepacia.
Infect. Immun.
66:874-877 |
| 12. | Dennis, J. J., and P. A. Sokol. 1995. Electrotransformation of Pseudomonas, p. 125-133. In J. A. Nickoloff (ed.), Electroporation and electrofusion of microorganisms. Humana Press, Clifton, N.J. |
| 13. |
DeShazer, D.,
P. J. Brett,
R. Carlyon, and D. E. Woods.
1997.
Mutagenesis of Burkholderia pseudomallei with Tn5-OT182: isolation of motility mutants and molecular characterization of the flagellin structural gene.
J. Bacteriol.
179:2116-2125 |
| 14. | DeShazer, D., and D. E. Woods. 1996. Broad-host range cloning and cassette vectors based on the R388 trimethoprim resistance gene. BioTechniques 20:762-764[Medline]. |
| 15. |
Dunnil, M. S.
1962.
Quantitative methods in the study of pulmonary pathology.
Thorax
17:320-328 |
| 16. |
Figuski, D. H., and D. R. Helinski.
1979.
Replication of an origin-containing derivative of plasmid RK2 dependent on a plasmid function provided in trans.
Proc. Natl. Acad. Sci. USA
76:1648-1652 |
| 17. | Gaballa, A., N. Liedam, and P. Cornelis. 1996. A cytochrome c biogenesis gene involved in pyoverdine production in Pseudomonas fluorescens ATCC 17400. Mol. Microbiol. 21:777-785[Medline]. |
| 18. | Gensberg, K., K. Hughes, and A. W. Smith. 1993. Siderophore-specific induction of iron uptake in Pseudomonas aeruginosa. J. Gen. Microbiol. 138:2381-2387. |
| 19. | Giardina, P. C., L. A. Foster, S. I. Toth, B. A. Roe, and D. W. Dyer. 1995. Identification of alcA, a Bordetella bronchiseptica gene necessary for alcaligin production. Gene 167:133-136[Medline]. |
| 20. |
Goldberg, J. B., and D. E. Ohman.
1984.
Cloning and expression in Pseudomonas aeruginosa of a gene involved in the production of alginate.
J. Bacteriol.
158:1115-1121 |
| 21. |
Govan, J. R. W.,
J. E. Hughes, and P. Vandamme.
1996.
Burkholderia cepacia: medical, taxonomic and ecological issues.
J. Med. Microbiol.
45:395-407 |
| 22. |
Herrero, M.,
V. de Lorenzo, and J. B. Neilands.
1988.
Nucleotide sequence of the iucD gene of the pColV-K30 aerobactin operon and topology of its product studied with phoA and lacZ gene fusions.
J. Bacteriol.
170:56-64 |
| 23. | Hoang, T. T., R. R. Karkhoff-Schweizer, A. J. Kutchma, and H. P. Schweizer. 1998. A broad host-range Flp-FRT recombination system for sip-specific excision of chromosomally-located DNA sequences: application for isolation of unmarked Pseudomonas aeruginosa mutants. Gene 212:77-86[Medline]. |
| 24. | Hopfl, P., W. Ludwig, K. H. Schleifer, and N. Larsen. 1989. The 23S ribosomal RNA higher-order structure of Pseudomonas cepacia and other prokaryotes. Eur. J. Biochem. 185:355-364[Medline]. |
| 25. | Koster, M., J. van de Vossenberg, J. Leong, and P. J. Weisbeek. 1993. Identification and characterization of the pupB gene encoding an inducible ferric-pseudobactin receptor of Pseudomonas putida WCS358. Mol. Microbiol. 8:591-601[Medline]. |
| 26. |
Leoni, L.,
A. Ciervo,
N. Orsi, and P. Visca.
1996.
Iron-regulated transcription of the pvdA gene in Pseudomonas aeruginosa: effect of Fur and PvdS on promoter activity.
J. Bacteriol.
178:2299-2313 |
| 27. |
Lewenza, S.,
B. Conway,
E. P. Greenberg, and P. A. Sokol.
1999.
Quorum sensing in Burkholderia cepacia: identification of the LuxRI homologs CepRI.
J. Bacteriol.
181:748-756 |
| 28. |
MacLachlan, P. R., and K. E. Sanderson.
1985.
Transformation of Salmonella typhimurium with plasmid DNA: differences between rough and smooth strains.
J. Bacteriol.
161:442-445 |
| 29. | Madden, T. L., R. L. Tatusov, and J. Zhang. 1996. Applications of network BLAST server. Methods Enzymol. 266:131-141[Medline]. |
| 30. | Mahenthiralingam, E., D. A. Simpson, and D. P. Speert. 1997. Identification and characterization of a novel DNA marker associated with epidemic strains of Burkholderia cepacia recovered from patients with cystic fibrosis. J. Clin. Microbiol. 35:808-816[Abstract]. |
| 31. | McMorran, B. J., M. E. Merriman, I. T. Rombel, and I. L. Lamont. 1996. Characterization of the pvdE gene which is required for pyoverdine synthesis in Pseudomonas aeruginosa. Gene 176:55-59[Medline]. |
| 32. |
Mei, B.,
A. D. Budde, and S. A. Leong.
1993.
sid1, a gene initiating siderophore biosynthesis in Ustilago maydis: molecular characterization, regulation by iron, and role in phytopathogenicity.
Proc. Natl. Acad. Sci. USA
90:903-907 |
| 33. | Merriman, T. R., and I. L. Lamont. 1993. Construction and use of a self-cloning promoter probe vector for gram-negative bacteria. Gene 126:17-23[Medline]. |
| 34. |
Merriman, T. R.,
M. E. Merriman, and I. L. Lamont.
1995.
Nucleotide sequence of pvdD, a pyoverdine biosynthetic gene from Pseudomonas aeruginosa: PvdD has similarity to peptide synthetases.
J. Bacteriol.
177:252-258 |
| 35. |
Meyer, J. M.,
D. Hohnadel, and F. Halle.
1989.
Cepabactin from Pseudomonas cepacia, a new type of siderophore.
J. Gen. Microbiol.
135:1479-1487 |
| 36. | Meyer, J.-M., V. Tran Van, A. Stintzi, O. Berge, and G. Winkelmann. 1995. Ornibactin production and transport properties in strains of Burkholderia vietnamiensis and Burkholderia cepacia (formerly Pseudomonas cepacia). Biometals 8:309-317[Medline]. |
| 37. | Mietzner, T. A., and S. A. Morse. 1994. The role of iron-binding proteins in the survival of pathogenic bacteria. Annu. Rev. Nutr. 14:471-493[Medline]. |
| 38. | Miller, J. H. 1972. Experiments in molecular genetics. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y. |
| 39. | Miyazaki, H., H. Kato, T. Nakazawa, and M. Tsuda. 1995. A positive regulatory gene, pvdS, for expression of pyoverdin biosynthetic genes in Pseudomonas aeruginosa PAO. Mol. Gen. Genet. 248:17-24[Medline]. |
| 40. | Nakayashiki, T., K. Nishimura, and H. Inokuchi. 1995. Cloning and sequencing of a previously identified gene that is involved in the biosynthesis of heme in Escherichia coli. Gene 153:67-70[Medline]. |
| 41. |
Ochsner, U. A., and M. L. Vasil.
1996.
Gene repression by the ferric uptake regulator in Pseudomonas aeruginosa: cycle selection of iron regulated genes.
Proc. Natl. Acad. Sci. USA
93:4409-4414 |
| 42. |
Ohman, D. E.,
J. Sadoff, and B. H. Iglewski.
1980.
Toxin A-deficient mutants of Pseudomonas aeruginosa PA-103: isolation and characterization.
Infect. Immun.
28:899-908 |
| 43. | Rodley, P. D., U. Römmling, and B. Tümmler. 1995. A physical genome map of the Burkholderia cepacia type strain. Mol. Microbiol. 17:57-67[Medline]. |
| 44. | Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. |
| 45. | Sasakawa, C., and M. Yoshikawa. 1987. A series of Tn5 variants with various drug-resistance markers and suicide vector for transposon mutagenesis. Gene 56:283-288[Medline]. |
| 46. | Schweizer, H. P. 1991. Escherichia-Pseudomonas shuttle vectors derived from pUC18/19. Gene 97:109-112[Medline]. |
| 47. | Schweizer, H. P. 1992. Allelic exchange in Pseudomonas aeruginosa using novel ColE1-type vectors and a family of cassettes containing a portable oriT and the counter-selectable Bacillus subtilis sacB marker. Mol. Microbiol. 6:1195-1204[Medline]. |
| 48. | Schweizer, H. P. 1993. Two plasmids, X1918 and Z1918, for easy recovery of the xylE and lacZ reporter genes. Gene 134:89-91[Medline]. |
| 49. | Schweizer, H. P. 1993. Small broad-host-range gentamicin resistance gene cassette for site specific insertion and deletion mutagenesis. BioTechniques 15:831-834[Medline]. |
| 50. | Schweizer, H. P., T. Klassen, and T. Hoang. 1996. Improved methods for gene analysis and expression in Pseudomonas spp., p. 229-237. In T. Nakazawa, K. Furukawa, D. Haas, and S. Silver (ed.), Molecular biology of pseudomonads. ASM Press, Washington, D.C. |
| 51. | Schwyn, B., and J. B. Neilands. 1987. Universal chemical assay for the detection and determination of siderophores. Anal. Biochem. 160:47-56[Medline]. |
| 52. | Simon, R., U. Priefer, and A. Puhler. 1983. A broad host range mobilization system for in vivo genetic engineering: transposon mutagenesis in gram negative bacteria. Bio/Technology 1:784-791. |
| 53. |
Sokol, P. A.
1986.
Production and utilization of pyochelin by clinical isolates of Pseudomonas cepacia.
J. Clin. Microbiol.
23:560-562 |
| 54. |
Sokol, P. A.,
C. J. Lewis, and J. J. Dennis.
1992.
Isolation of a novel siderophore from Pseudomonas cepacia.
J. Med. Microbiol.
36:184-189 |
| 55. |
Sokol, P. A., and D. E. Woods.
1984.
Relationship of iron and extracellular virulence factors to Pseudomonas aeruginosa lung infections.
J. Med. Microbiol.
18:125-133 |
| 56. | Sokol, P. A., and D. E. Woods. 1988. Effect of pyochelin on Pseudomonas cepacia respiratory infections. Microb. Pathog. 5:197-205[Medline]. |
| 57. |
Stephan, H.,
S. Freund,
W. Beck,
G. Jung,
J.-M. Meyer, and G. Winkelmann.
1993.
Ornibactins a new family of siderophores from Pseudomonas.
Biometals
6:93-100[Medline].
|
| 58. | Stephan, H., S. Freund, J. M. Meyer, G. Winklemann, and G. Gung. 1993. Structure elucidation of the gallium-ornibactin complex by 2D-NMR spectroscopy. Liebigs Ann. Chem. 1993:43-48. |
| 59. |
Straus, D. C.,
D. E. Woods,
M. K. Lonon, and C. W. Garner.
1988.
The importance of extracellular antigens in Pseudomonas cepacia infections.
J. Med. Microbiol.
26:269-280 |
| 60. |
Strohmaier, H.,
P. Remler,
W. Renner, and G. Högenauer.
1995.
Expression of genes kdsA and kdsB involved in 3-deoxy-D-manno-octulosonic acid metabolism and biosynthesis of enterobacterial lipopolysaccharide is growth phase regulated primarily at the transcriptional level in Escherichia coli K-12.
J. Bacteriol.
177:4488-4500 |
| 61. | Tabacchioni, S., P. Visca, L. Chiarine, A. Bevivino, C. DiSerio, S. Facelli, and R. Fani. 1995. Molecular characterization of rhizosphere and clinical isolates of Burkholderia cepacia. Res. Microbiol. 146:531-542[Medline]. |
| 62. |
Tsuda, M.,
H. Miyzzaki, and T. Nakazawa.
1995.
Genetic and physical mapping of genes involved in pyoverdin production in Pseudomonas aeruginosa PAO.
J. Bacteriol.
177:423-431 |
| 63. |
Vandamme, P.,
B. Holmes,
M. Vancanneyt,
T. Coenye,
B. Hoste,
R. Coopman,
H. Revets,
S. Lauwers,
M. Gillis,
K. Kersters, and J. R. W. Govan.
1997.
Occurrence of multiple genomovars of Burkholderia cepacia in cystic fibrosis patients and proposal of Burkholderia multivorans sp. nov.
Int. J. Syst. Bacteriol.
47:1188-1200 |
| 64. |
Visca, P.,
A. Ciervo, and N. Orsi.
1994.
Cloning and nucleotide sequence of the pvdA gene encoding the pyoverdin biosynthetic enzyme L-ornithine N5-oxygenase in Pseudomonas aeruginosa.
J. Bacteriol.
176:1128-1140 |
| 65. |
Visca, P.,
A. Ciervo,
V. Sanfilippo, and N. Orsi.
1993.
Iron-regulated salicylate synthesis by Pseudomonas spp.
J. Gen. Microbiol.
139:1995-2001 |
| 66. |
Visca, P.,
L. Serino, and N. Orsi.
1992.
Isolation and characterization of Pseudomonas aeruginosa mutants blocked in the synthesis of pyoverdin.
J. Bacteriol.
174:5727-5731 |
| 67. |
Wahl, G. M.,
K. A. Lewis,
J. C. Ruiz,
B. Rothenberg,
J. Zhao, and G. A. Evans.
1987.
Cosmid vectors for rapid genomic walking, restriction mapping and gene transfer.
Proc. Natl. Acad. Sci. USA
84:2160-2164 |
| 68. | Woods, D. 1984. Oligonucleotide screening of cDNA libraries. Focus 6:1-2. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»